Literature DB >> 9161312

Acute angle closure glaucoma associated with paroxetine.

T Eke1, A K Bates.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9161312      PMCID: PMC2126635          DOI: 10.1136/bmj.314.7091.1387

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  11 in total

1.  Reports of acute angle closure glaucoma-related adverse events with SSRIs: results of a disproportionality analysis.

Authors:  Manfred Hauben; Lester Reich
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Bilateral symptomatic angle closure associated with a regular dose of citalopram, an SSRI antidepressant.

Authors:  P Massaoutis; D Goh; P J Foster
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

Review 3.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

4.  Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Francesco Semeraro; Adolfo Sebastiani
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

Review 5.  SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Adolfo Sebastiani
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 6.  Drug-induced glaucomas: mechanism and management.

Authors:  Ramesh C Tripathi; Brenda J Tripathi; Chris Haggerty
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

7.  Citalopram associated with acute angle-closure glaucoma: case report.

Authors:  Robert Croos; Srinivasa Thirumalai; Sabit Hassan; Jane Da Roza Davis
Journal:  BMC Ophthalmol       Date:  2005-10-04       Impact factor: 2.209

8.  Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial.

Authors:  Maria Paile-Hyvärinen; Kristian Wahlbeck; Johan G Eriksson
Journal:  BMC Fam Pract       Date:  2003-05-14       Impact factor: 2.497

9.  Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial.

Authors:  Maria Paile-Hyvärinen; Kristian Wahlbeck; Johan G Eriksson
Journal:  BMC Fam Pract       Date:  2007-06-15       Impact factor: 2.497

10.  Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients.

Authors:  Hsin-Yi Chen; Cheng-Li Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.